[Glaucoma surgeries: Long-term results - A review].

Les principales chirurgies du glaucome : résultats à long terme – une revue de la littérature.
Chirurgie du glaucome Chirurgie filtrante Cyclo-photocoagulation Cyclophotocoagulation Filtering surgery Glaucoma surgery MIGS Nerf optique Optic nerve

Journal

Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 19 07 2023
revised: 12 08 2023
accepted: 31 08 2023
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: aheadofprint

Résumé

The surgical treatment of glaucoma has been and is still based on filtering surgeries, commonly used for about half a century. The safety and efficacy of these techniques have been well described, as it has also been done for cyclophotocoagulation and valves or tubes, indicated in France mostly for refractory glaucoma. Minimally invasive glaucoma surgeries have emerged in recent decades, increasing the number of therapeutic options, and allowing treatment decisions to be as patient-centered as possible. Most of these techniques have now been studied for more than five years. Since glaucoma is a chronic, progressive optic neuropathy, the sustainability of each surgery's results is essential. The amount of available data concerning long-term efficacy and safety of glaucoma surgeries is increasing, so we have decided to describe it through this review of the literature.

Identifiants

DOI: 10.1016/j.jfo.2024.104098 PMID: 39208602
pubmed: 39208602
pii: S0181-5512(24)00043-3
doi: 10.1016/j.jfo.2024.104098
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

104098

Informations de copyright

Copyright © 2024 Elsevier Masson SAS. All rights reserved.

Auteurs

M Tatry (M)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France. Electronic address: mathias.tatry@gmail.com.

P Bastelica (P)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France; Institut de la Vision, IHU FOReSIGHT, Sorbonne Université, Paris, France.

E Brasnu (E)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France; Institut de la Vision, IHU FOReSIGHT, Sorbonne Université, Paris, France; Inserm 1423, IHU FOReSIGHT, hôpital national de la vision, centre d'investigation clinique, Paris, France.

J Buffault (J)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France; Institut de la Vision, IHU FOReSIGHT, Sorbonne Université, Paris, France; IHU FOReSIGHT, hôpital Ambroise-Paré, AP-HP, université de Versailles Saint-Quentin-en-Yvelines, Versailles, France; Inserm 1423, IHU FOReSIGHT, hôpital national de la vision, centre d'investigation clinique, Paris, France.

P Hamard (P)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France.

C Baudouin (C)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France; Institut de la Vision, IHU FOReSIGHT, Sorbonne Université, Paris, France; IHU FOReSIGHT, hôpital Ambroise-Paré, AP-HP, université de Versailles Saint-Quentin-en-Yvelines, Versailles, France; Inserm 1423, IHU FOReSIGHT, hôpital national de la vision, centre d'investigation clinique, Paris, France.

A Labbé (A)

Service 3, IHU FOReSIGHT, hôpital national de la vision des 15-20, Paris, France; Institut de la Vision, IHU FOReSIGHT, Sorbonne Université, Paris, France; IHU FOReSIGHT, hôpital Ambroise-Paré, AP-HP, université de Versailles Saint-Quentin-en-Yvelines, Versailles, France; Inserm 1423, IHU FOReSIGHT, hôpital national de la vision, centre d'investigation clinique, Paris, France.

Classifications MeSH